Try our Advanced Search for more refined results
February 02, 2024
Baker v. Cassava Sciences, Inc. et al
Case Number:
1:24-cv-00977
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 05, 2024
Biotech Co. Hit With Investor Suit Over Alzheimer's Drug Trial
Biotechnology company Cassava Sciences and two of its executives were hit with a proposed class action over allegations that a co-developer of the company's Alzheimer's drug was under investigation by his employer for possible data manipulation, which Cassava concealed from the public.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login